CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843199512
- Phone
- (214) 612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice · Executive or director change
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K/A Event Executive or director change
- 8-K Event Other events
- 8-K Event Executive or director change
Page 3 of 6 · 105 filings